Xvivo Perfusion AB (publ) (LON: 0RKL)
London
· Delayed Price · Currency is GBP · Price in SEK 429.50
+9.72 (2.32%)
Jan 23, 2025, 1:44 PM BST
Xvivo Perfusion AB Market Cap
Xvivo Perfusion AB has a market cap or net worth of 968.17 million as of January 23, 2025. Its market cap has increased by 24.56% in one year.
Market Cap
968.17M
Enterprise Value
936.81M
Revenue
55.22M
Ranking
n/a
PE Ratio
64.43
Stock Price
429.50
Market Cap Chart
Since October 8, 2012, Xvivo Perfusion AB's market cap has increased from 34.98M to 968.17M, an increase of 2,667.81%. That is a compound annual growth rate of 31.00%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 167.37B |
| GSK plc | 55.25B |
| Haleon | 33.80B |
| Smith & Nephew | 8.96B |
| ConvaTec Group | 4.94B |
| Hikma Pharmaceuticals | 4.62B |
| HUTCHMED (China) | 2.00B |
| Oxford Nanopore Technologies | 1.37B |